Advertisement

Intensivtherapie nach Organtransplantation

  • E. R. Kuse
Chapter
  • 1.7k Downloads

Auszug

Nach langen Diskussionen bietet das Transplantationsgesetz, das seit 01.12.1997 in Kraft ist, Rechtssicherheit. Das Gesetz dient dem Schutz des Spenders und des Empfängers, und es bietet Rechtssicherheit für alle in der Transplantationsmedizin Tätigen. Das Gesetz legt die Rechte und Verpflichtungen der Beteiligten und die Wege der Organspende und -vermittlung fest. Das Gesetz unterscheidet zwischen der Organentnahme bei Lebenden und bei Verstorbenen und legt die Rahmenbedingungen fest. Die Umsetzung der Todesbestimmung soll nach den Erkenntnissen der medizinischen Wissenschaft erfolgen und ist in den Richtlinien der Bundesärztekammer (3. Fortschreibung 1997) festgelegt worden.

Literatur

  1. 1.
    Kuse E, Weimann A (1994) Besonderheiten im Rahmen der Transplantationschirurgie. In: Hartig W (Hrsg) Moderne Infusionstherapie — Künstliche Ernährung. Zuckschwert, München, S 529–534Google Scholar
  2. 2.
    Wiesner RH et al. (1988) Selective bowel decontamination to decrease gram-negativeaerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation 45:570–574PubMedCrossRefGoogle Scholar
  3. 3.
    Ozawa K, Mori K, Morimoto T (1994) Evaluation of hepatic function. CurrOpin Gen Surg 17–23Google Scholar
  4. 4.
    Wade JJ et al. (1995) Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 21:1328–1336PubMedCrossRefGoogle Scholar
  5. 5.
    Tollemar J, Hockerstedt K, Ericzon BG, Jalanko H, Ringden O (1995) Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study. Transplantation 59:45–50PubMedCrossRefGoogle Scholar
  6. 6.
    Kusne S. et al. (1999) Cytomegalovirus PP65 antigenemia monitoring as a guidefor preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 68:1125–1131PubMedCrossRefGoogle Scholar
  7. 7.
    Liebau P et al. (1996) Management of herpes simplex virus type 1 pneumonia following liver transplantation. Infection 24:130–135PubMedCrossRefGoogle Scholar
  8. 8.
    Schlitt HJ et al. (1991) Differentiation of liver graft dysfunction by transplant aspiration cytology. Transplantation 51:786–793PubMedCrossRefGoogle Scholar
  9. 9.
    Egawa H et al. (1999) Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation 67:712–717PubMedCrossRefGoogle Scholar
  10. 10.
    Blanco R, DeGirolami U, Jenkins RL, Khettry U (1995) Neuropathology of liver transplantation. Clin Neuropathol 14:109–117PubMedGoogle Scholar
  11. 11.
    Lee YJ et al. (1996) Neurologic complications after orthotopic liver transplantation including central pontine myelinolysis. Transplant Proc 28:1674–1675PubMedGoogle Scholar
  12. 12.
    Humar A et al. (1999) The association between acute rejection and chronic rejection in kidney transplantation. Transplant Proc 31:1302–1303PubMedCrossRefGoogle Scholar
  13. 13.
    MacMillan N et al. (1998) Venous graft thrombosis in clinical pancreas transplantation: options for a rescue treatment. Transplant Proc 30: 425–426PubMedCrossRefGoogle Scholar
  14. 14.
    Smets YF et al. (1997) Infectious disease complications of simultaneous pancreas kidney transplantation. Nephrol Dial Transplant 12: 764–771PubMedCrossRefGoogle Scholar
  15. 15.
    Glogar D et al. (1990) Heart transplantation: indication, selection criteria and patient management. Wien Med Wochenschr 140:287–289PubMedGoogle Scholar
  16. 16.
    Kobashigawa JA (1998) Advances in immunosuppression for heart transplantation. Adv Card Surg 10:155–174PubMedGoogle Scholar
  17. 17.
    Golshayan Det al. (1998) Incidence and prognostic value of electrocardiographic abnormalities after heart transplantation. Clin Cardiol 21:680–684PubMedCrossRefGoogle Scholar
  18. 18.
    Rourke TK, Droogan MT, Ohler L (1999) Heart transplantation: state of the art. AACN Clin Issues 10:185–201PubMedCrossRefGoogle Scholar
  19. 19.
    Hammer S et al. (1998) Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation. Transpl Immunol 6:235–241PubMedCrossRefGoogle Scholar
  20. 20.
    De Maria R et al. (1996) Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation. J Heart Lung Transplant 15:124–135PubMedGoogle Scholar
  21. 21.
    Frimat L et al. (1998) Treatment of end-stage renal failure after heart transplantation. Nephrol Dial Transplant 13:2905–2908PubMedCrossRefGoogle Scholar
  22. 22.
    Edelman JD, Kotloff RM (1997) Lung transplantation. A disease-specific approach. Clin Chest Med 18:627–644PubMedCrossRefGoogle Scholar
  23. 23.
    Hausen B, Morris RE (1997) Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies. Clin Chest Med 18:353–366PubMedCrossRefGoogle Scholar
  24. 24.
    Struber M, Hirt SW, Cremer J, Harringer W, Haverich A (1999) Surfactant replacement in reperfusion injury after clinical lung transplantation. Intensive Care Med 25:862–864PubMedCrossRefGoogle Scholar
  25. 25.
    Verleden GM et al. (1999) Cyclophosphamide rescue therapy for chronic rejection after lung transplantation. J Heart Lung Transplant 18: 1139–1142PubMedCrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2008

Authors and Affiliations

  • E. R. Kuse
    • 1
  1. 1.Zentrale Klinik für Anästhesie, operative Intensivmedizin u. SchmerztherapieKlinikum Salzgitter GmbHSalzgitter

Personalised recommendations